Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

2843 Lack of Knowledge About Follow-Up Colonoscopy in Patients With Biopsy Proven Advanced Colorectal Polyps: A Major Clinical and Medicolegal Challenge

View through CrossRef
INTRODUCTION: The most recent guidelines from the American College of Gastroenterology recommend that patients with biopsy proven advanced colorectal polyps undergo repeat surveillance colonoscopy at a minimum of three years following resection. The rationale is based on rates of recurrence and progression to colorectal cancer. In this report we quantitate the knowledge of patients with biopsy proven advanced colorectal polyps about if, and when, they need a repeat colonoscopy. METHODS: Methods: Written informed consents were obtained and brief telephone interviews conducted by trained interviewers among 84 patients with biopsy proven advanced colorectal polyps. In semi-structured questionnaires that included eleven questions the patients provided self-reports about their awareness of the need to have a repeat colonoscopy as well as the proper surveillance interval. RESULTS: Among the 84 patients, who ranged in age from 41-91 years, 24 (28.6%) were unaware of either the need for a repeat colonoscopy or the proper surveillance interval. These included 10 (12.0%) who were not even aware that they required a follow up colonoscopy and 14 (16.6%) who were unaware of the proper three year interval. CONCLUSION: Discussion: These data pose medical and legal challenges to clinicians to educate patients with biopsy proven advanced colorectal polyps about their need for repeat colonoscopy as well as the proper surveillance interval to reduce their risks of colorectal cancer. Specifically, without proper knowledge of the advanced colorectal polyp three year surveillance protocol, 28.6% of these high risk patients would have forgone or delayed the colonoscopy. With advances in technology and digitized medical records, clinicians may need to rely on a more objective and reproducible centralized database of past colonoscopy findings rather than self-reports. These clinical and medicolegal challenges may also be addressed, at least in part, by automated recalls that ensure there is a safety net to remind patients of their subsequent colonoscopy appointment. The success of these strategies will depend on meticulous attention by the clinician to ensure accurate data pertaining to guideline based appropriate surveillance intervals for colonoscopy. These strategies may also reduce any overutilization of colonoscopies. Of far greater import, the achievement of this goal may reduce morbidity and mortality from colorectal cancer in high risk patients with advanced colorectal polyps.
Title: 2843 Lack of Knowledge About Follow-Up Colonoscopy in Patients With Biopsy Proven Advanced Colorectal Polyps: A Major Clinical and Medicolegal Challenge
Description:
INTRODUCTION: The most recent guidelines from the American College of Gastroenterology recommend that patients with biopsy proven advanced colorectal polyps undergo repeat surveillance colonoscopy at a minimum of three years following resection.
The rationale is based on rates of recurrence and progression to colorectal cancer.
In this report we quantitate the knowledge of patients with biopsy proven advanced colorectal polyps about if, and when, they need a repeat colonoscopy.
METHODS: Methods: Written informed consents were obtained and brief telephone interviews conducted by trained interviewers among 84 patients with biopsy proven advanced colorectal polyps.
In semi-structured questionnaires that included eleven questions the patients provided self-reports about their awareness of the need to have a repeat colonoscopy as well as the proper surveillance interval.
RESULTS: Among the 84 patients, who ranged in age from 41-91 years, 24 (28.
6%) were unaware of either the need for a repeat colonoscopy or the proper surveillance interval.
These included 10 (12.
0%) who were not even aware that they required a follow up colonoscopy and 14 (16.
6%) who were unaware of the proper three year interval.
CONCLUSION: Discussion: These data pose medical and legal challenges to clinicians to educate patients with biopsy proven advanced colorectal polyps about their need for repeat colonoscopy as well as the proper surveillance interval to reduce their risks of colorectal cancer.
Specifically, without proper knowledge of the advanced colorectal polyp three year surveillance protocol, 28.
6% of these high risk patients would have forgone or delayed the colonoscopy.
With advances in technology and digitized medical records, clinicians may need to rely on a more objective and reproducible centralized database of past colonoscopy findings rather than self-reports.
These clinical and medicolegal challenges may also be addressed, at least in part, by automated recalls that ensure there is a safety net to remind patients of their subsequent colonoscopy appointment.
The success of these strategies will depend on meticulous attention by the clinician to ensure accurate data pertaining to guideline based appropriate surveillance intervals for colonoscopy.
These strategies may also reduce any overutilization of colonoscopies.
Of far greater import, the achievement of this goal may reduce morbidity and mortality from colorectal cancer in high risk patients with advanced colorectal polyps.

Related Results

Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
1175 Ileal Carcinoid Tumors Detected During Screening versus Diagnostic Colonoscopy: Comparison of Tumor Characteristics
1175 Ileal Carcinoid Tumors Detected During Screening versus Diagnostic Colonoscopy: Comparison of Tumor Characteristics
INTRODUCTION: Small intestinal carcinoid tumors are the most common type of small bowel malignancy observed. Most are indolent and incidentally found in asymptomatic pa...
ARTIFICIAL INTELLIGENCE APPLICATION IN COLONOSCOPY SCREENING: A LITERATURE REVIEW
ARTIFICIAL INTELLIGENCE APPLICATION IN COLONOSCOPY SCREENING: A LITERATURE REVIEW
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally and remains a leading cause of cancer-related deaths. Despite the effectiveness of colonosc...
EP.TU.313Colorectal cancer follow up: Can CT Colonography replace Colonoscopy?
EP.TU.313Colorectal cancer follow up: Can CT Colonography replace Colonoscopy?
Abstract Aims Current guidelines recommend surveillance colonoscopy at one year following Colorectal Cancer Resection (CCR), yea...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract Introduction Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Screening Colonoscopy Uptake Among Adult Stroke Survivors: Findings from the 2022 BRFSS Data
Screening Colonoscopy Uptake Among Adult Stroke Survivors: Findings from the 2022 BRFSS Data
Background/Objectives: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths globally. Screening for cancer helps to prevent comorbid conditions among indivi...
Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test
Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test
Goals: We analyzed if the predictive value of multitarget stool-based DNA (mt-sDNA) varied when patients had pre-existing known colorectal cancer (CRC) risk factors. ...

Back to Top